IRCT20181226042136N2RecruitingPhase 3
Evaluation of the effect of mesotherapy with a combination of biotin and dexpanthenol in the treatment of androgenetic alopecia in women
Trial Snapshot
- Phase
- Phase 3
- Status
- Recruiting
- Enrollment
- 36
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- 18 years to 45 years (—)
- Sex
- Female
Inclusion Criteria
- •Having a female pattern hair loss
- •Do not use other hair loss treatments at the time of enrollment
- •Do not use temporary and permanent hair dye and curl or straighten hair
- •Do not use aspirin, warfarin, steroids, oral retinoids, hormones or cytotoxic drugs
- •Absence of pregnancy and lactation
- •Absence of high androgenic blood levels, irregular periods, acne and hirsutism, thromboembolic events, low ferritin blood levels and impaired TSH
Exclusion Criteria
- •Allergic reaction to the drug used
- •Failure to complete the course of treatment and failure to refer for follow-up, which results in a drawing on the case file or the patient
- •Local reactions such as abscesses, inflammation and cellulite at the injection site
- •The patient's decision not to participate in the study
Investigators
Similar Trials
Not yet recruiting
Unknown
Investigating the effect of piroxicam mesotherapy in the treatment of tennis elbowateral epicondylitis.Lateral epicondylitisM77.1IRCT20230515058198N1Shiraz University of Medical Sciences36
Completed
Phase 3
efficacy of mesotherapy in the treatment of chronic radiculopathychronic radiculopathy.Radiculopathy, lumbosacral regionM54.17IRCT20231203060255N1Esfahan University of Medical Sciences60
Recruiting
Phase 3
A clinical trial to study the difference between surgery and the infiltration of drug in lipoma( benign tumor of fat)CTRI/2018/04/013488Ongoing intramural project in the department of surgical disciplines AIIMS
Recruiting
Not Applicable
Effect of Mesotherapy and RF laser in the Treatment of Double chiIRCT20220615055190N1Islamic Azad University100
Not yet recruiting
Phase 4
Open labelled, single arm, interventional study of dutasteride injection for androgenetic alopecia.CTRI/2024/03/064041CUTIS Academy of Cutaneous Sciences
